HOTCHKIS & WILEY's SRPT Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 565,720 shares of Sarepta Therapeutics, Inc. (SRPT) worth $10.17 M, representing 0.03% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, HOTCHKIS & WILEY has initiated a new position in SRPT, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 5,570 shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's Sarepta Therapeutics (SRPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sarepta Therapeutics (SRPT) Trades by HOTCHKIS & WILEY
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +5,570 | Add 0.99% | 565,720 | $17.97 |
| Q1 2026 | +560,150 | New Buy | 560,150 | $21.76 |
HOTCHKIS & WILEY's Sarepta Therapeutics Investment FAQs
HOTCHKIS & WILEY first purchased Sarepta Therapeutics, Inc. (SRPT) in Q1 2026, acquiring 560,150 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held Sarepta Therapeutics, Inc. (SRPT) for 2 quarters since Q1 2026.
HOTCHKIS & WILEY's largest addition to Sarepta Therapeutics, Inc. (SRPT) was in Q1 2026, adding 560,150 shares worth $12.19 M.
According to the latest 13F filing for Q2 2026, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 565,720 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $10.17 M.
As of the Q2 2026 filing, Sarepta Therapeutics, Inc. (SRPT) represents approximately 0.03% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.
HOTCHKIS & WILEY's peak holding in Sarepta Therapeutics, Inc. (SRPT) was 565,720 shares, as reported at the end of Q2 2026.